NCT06559163Phase 2Active not recruiting

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Study sponsor: Zenas BioPharma (USA), LLC

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-09Estimated

Enrollment · participants190Actual

Source updated2026-08-18Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-08-18 · 3 fields changed

Participant count type changed

− Before

~~Estimated~~

+ After

Actual

Primary completion date changed

− Before

~~Jun 2026~~

+ After

Sep 2026

Recruitment status changed

− Before

~~Recruiting~~

+ After

Active not recruiting

Check registry source